{"DataElement":{"publicId":"14680496","version":"1","preferredName":"Metastasis Primary Neoplasm Tissue or Organ of Origin Anatomic Site","preferredDefinition":"The named location of or within the body of the primary tumor origin from which the cancer cells have migrated.","longName":"14680484v1.00:14679065v1.00","context":"CIP","contextVersion":"2.31","DataElementConcept":{"publicId":"14680484","version":"1","preferredName":"Metastasis Primary Neoplasm Tissue or Organ of Origin","preferredDefinition":"The spread or migration of cancer cells from one part of the body (the organ in which it first appeared) to another. The secondary tumor contains cells that are like those in the original (primary) tumor.:A tumor at the original site of origin._The anatomic site of a tumor or pathological process.","longName":"2761292v1.00:14714148v1.00","context":"CIP","contextVersion":"2.31","ObjectClass":{"publicId":"2761292","version":"1","preferredName":"Metastasis","preferredDefinition":"Cancer that has spread from the organ in which it first appeared to another organ. For example, breast cancer cells may spread (metastasize) to the lungs and cause the growth of a new tumor. When this happens, the disease is called metastatic breast cancer.","longName":"C19151","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Metastasis","conceptCode":"C19151","definition":"The spread or migration of cancer cells from one part of the body (the organ in which it first appeared) to another. The secondary tumor contains cells that are like those in the original (primary) tumor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5093E570-4BA4-148F-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-06-26","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2008-06-26","modifiedBy":"ONEDATA","dateModified":"2008-06-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"14714148","version":"1","preferredName":"Primary Neoplasm Tissue or Organ of Origin","preferredDefinition":"A tumor at the original site of origin._The anatomic site of a tumor or pathological process.","longName":"C8509:C156422","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Primary Neoplasm","conceptCode":"C8509","definition":"A tumor at the original site of origin.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Tissue or Organ of Origin","conceptCode":"C156422","definition":"The anatomic site of a tumor or pathological process.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0F7ADFB8-FE6C-3170-E063-731AD00A09F1","latestVersionIndicator":"Yes","beginDate":"2024-01-21","endDate":null,"createdBy":"JKNABLE","dateCreated":"2024-01-21","modifiedBy":"JKNABLE","dateModified":"2024-01-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435022","version":"1","preferredName":"Disease, Disorder or Finding","preferredDefinition":"Specification of human conditions relevant to cancer. This includes observations, test results, history, and other concepts relevant to characterization of human cancer-related conditions. Non-neoplastic conditions of interest are also included.","longName":"C7057","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D9-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"TCIA:TheCancerImagingArchive","workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"0F2A36C6-8EA2-0714-E063-731AD00A19E9","latestVersionIndicator":"Yes","beginDate":"2024-01-17","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2024-01-17","modifiedBy":"JKNABLE","dateModified":"2024-01-21","changeDescription":null,"administrativeNotes":"1/17/24 Created for TCIA Pretreat-MetsToBrain-Masks variable. bf","unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"14679065","version":"1","preferredName":"Metastasis Origin Anatomic Site","preferredDefinition":"The spread or migration of cancer cells from one part of the body (the organ in which it first appeared) to another. The secondary tumor contains cells that are like those in the original (primary) tumor._The place where something begins or comes from in either the sense of a physical location or a metaphysical source._Named locations of or within the body.","longName":"14679065v1.00","context":"CIP","contextVersion":"2.31","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":null,"minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Breast Cancer","valueDescription":null,"ValueMeaning":{"publicId":"5581329","version":"1","preferredName":"Breast Carcinoma","longName":"5581329","preferredDefinition":"A carcinoma arising from the breast, most commonly the terminal ductal-lobular unit. It is the most common malignant tumor in females. Risk factors include country of birth, family history, menstrual and reproductive history, fibrocystic disease and epithelial hyperplasia, exogenous estrogens, contraceptive agents, and ionizing radiation. The vast majority of breast carcinomas are adenocarcinomas (ductal or lobular). Breast carcinoma spreads by direct invasion, by the lymphatic route, and by the blood vessel route. The most common site of lymph node involvement is the axilla.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Carcinoma","conceptCode":"C4872","definition":"A carcinoma arising from the breast, most commonly the terminal ductal-lobular unit. It is the most common malignant tumor in females. Risk factors include country of birth, family history, menstrual and reproductive history, fibrocystic disease and epithelial hyperplasia, exogenous estrogens, contraceptive agents, and ionizing radiation. The vast majority of breast carcinomas are adenocarcinomas (ductal or lobular). Breast carcinoma spreads by direct invasion, by the lymphatic route, and by the blood vessel route. The most common site of lymph node involvement is the axilla.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"42019733-B6D0-634F-E053-F662850A5A61","latestVersionIndicator":"Yes","beginDate":"2016-11-23","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2016-11-23","modifiedBy":"FINCHAMB","dateModified":"2024-01-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F265DBE-EBA0-093E-E063-731AD00A2B63","beginDate":"2024-01-17","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2024-01-17","modifiedBy":"FINCHAMB","dateModified":"2024-01-17","deletedIndicator":"No"},{"value":"Small Cell Lung Cancer","valueDescription":null,"ValueMeaning":{"publicId":"3297699","version":"1","preferredName":"Small Cell Lung Carcinoma","longName":"3297699","preferredDefinition":"A highly aggressive subtype of lung carcinoma characterized by the presence of malignant small cells and necrosis. Metastatic disease is usually present at the time of diagnosis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lung Small Cell Carcinoma","conceptCode":"C4917","definition":"A highly aggressive carcinoma with neuroendocrine differentiation arising from the lung. It is characterized by the presence of malignant small cells and necrosis. Metastatic disease is usually present at the time of diagnosis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B035F07A-837C-9251-E040-BB89AD4303FC","latestVersionIndicator":"Yes","beginDate":"2011-10-26","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-10-26","modifiedBy":"FINCHAMB","dateModified":"2024-01-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F265DBE-EBA1-093E-E063-731AD00A2B63","beginDate":"2024-01-17","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2024-01-17","modifiedBy":"FINCHAMB","dateModified":"2024-01-17","deletedIndicator":"No"},{"value":"Melanoma","valueDescription":null,"ValueMeaning":{"publicId":"5581342","version":"1","preferredName":"Melanoma","longName":"5581342","preferredDefinition":"A malignant, usually aggressive tumor composed of atypical, neoplastic melanocytes. Most often, melanomas arise in the skin (cutaneous melanomas) and include the following histologic subtypes: superficial spreading melanoma, nodular melanoma, acral lentiginous melanoma, and lentigo maligna melanoma. Cutaneous melanomas may arise from acquired or congenital melanocytic or dysplastic nevi. Melanomas may also arise in other anatomic sites including the gastrointestinal system, eye, urinary tract, and reproductive system. Melanomas frequently metastasize to lymph nodes, liver, lungs, and brain.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Melanoma","conceptCode":"C3224","definition":"A malignant, usually aggressive tumor composed of atypical, neoplastic melanocytes. Most often, melanomas arise in the skin (cutaneous melanomas) and include the following histologic subtypes: superficial spreading melanoma, nodular melanoma, acral lentiginous melanoma, and lentigo maligna melanoma. Cutaneous melanomas may arise from acquired or congenital melanocytic or dysplastic nevi. Melanomas may also arise in other anatomic sites including the gastrointestinal system, eye, urinary tract, and reproductive system. Melanomas frequently metastasize to lymph nodes, liver, lungs, and brain.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"42019733-B8A2-634F-E053-F662850A5A61","latestVersionIndicator":"Yes","beginDate":"2016-11-23","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2016-11-23","modifiedBy":"FINCHAMB","dateModified":"2024-01-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F265DBE-EBA2-093E-E063-731AD00A2B63","beginDate":"2024-01-17","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2024-01-17","modifiedBy":"FINCHAMB","dateModified":"2024-01-17","deletedIndicator":"No"},{"value":"Non Small Cell Lung Cancer","valueDescription":null,"ValueMeaning":{"publicId":"3534668","version":"1","preferredName":"NSCLC","longName":"3534668","preferredDefinition":"A group of at least three distinct histological types of lung cancer, including squamous cell carcinoma, adenocarcinoma, and large cell carcinoma.  Non-small cell lung carcinomas have a poor response to conventional chemotherapy.  --2002","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lung Non-Small Cell Carcinoma","conceptCode":"C2926","definition":"A group of at least three distinct histological types of lung cancer, including non-small cell squamous cell carcinoma, adenocarcinoma, and large cell carcinoma. Non-small cell lung carcinomas have a poor response to conventional chemotherapy.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C597D472-1BE4-C3F6-E040-BB89AD434BBD","latestVersionIndicator":"Yes","beginDate":"2012-07-24","endDate":null,"createdBy":"LEL","dateCreated":"2012-07-24","modifiedBy":"FINCHAMB","dateModified":"2024-01-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F265DBE-EBA3-093E-E063-731AD00A2B63","beginDate":"2024-01-17","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2024-01-17","modifiedBy":"FINCHAMB","dateModified":"2024-01-17","deletedIndicator":"No"},{"value":"Renal Cell Carcinoma","valueDescription":null,"ValueMeaning":{"publicId":"3248535","version":"1","preferredName":"Renal Cell Carcinoma","longName":"3248535","preferredDefinition":"Cancer that develops in the lining of the renal tubules, which filter the blood and produce urine.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Renal Cell Carcinoma","conceptCode":"C9385","definition":"A carcinoma arising from the renal parenchyma.  There is a strong correlation between cigarette smoking and the development of renal cell carcinoma.  The clinical presentation includes : hematuria, flank pain and a palpable lumbar mass.  A high percentage of renal cell carcinomas are diagnosed when an ultrasound is performed for other purposes.  Radical nephrectomy is the standard intervention procedure.  Renal cell carcinoma is generally considered to be resistant to radiation treatment and chemotherapy.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A6BBE041-BA15-9503-E040-BB89AD435A00","latestVersionIndicator":"Yes","beginDate":"2011-06-27","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-06-27","modifiedBy":"FINCHAMB","dateModified":"2024-01-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F265DBE-EBA4-093E-E063-731AD00A2B63","beginDate":"2024-01-17","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2024-01-17","modifiedBy":"FINCHAMB","dateModified":"2024-01-17","deletedIndicator":"No"},{"value":"Other","valueDescription":null,"ValueMeaning":{"publicId":"6431768","version":"1","preferredName":"Other","longName":"6431768v1.00","preferredDefinition":"Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"762A692A-EEF7-29A1-E053-F662850A9EA9","latestVersionIndicator":"Yes","beginDate":"2018-09-18","endDate":null,"createdBy":"WINCHC","dateCreated":"2018-09-18","modifiedBy":"GDEEN","dateModified":"2024-01-22","changeDescription":null,"administrativeNotes":"2023.2.1 Alt VM added per ticket request CADSR0001995. ak","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F265DBE-EBA5-093E-E063-731AD00A2B63","beginDate":"2024-01-17","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2024-01-17","modifiedBy":"FINCHAMB","dateModified":"2024-01-17","deletedIndicator":"No"},{"value":"Gastrointestinal Cancers","valueDescription":null,"ValueMeaning":{"publicId":"6832472","version":"1","preferredName":"Digestive System Neoplasm","longName":"6832472","preferredDefinition":"A benign or malignant neoplasm involving any part of the digestive system.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Digestive System Neoplasm","conceptCode":"C3052","definition":"A benign or malignant neoplasm involving any part of the digestive system.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8E9A76BA-9876-69B5-E053-F662850AA843","latestVersionIndicator":"Yes","beginDate":"2019-07-26","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-26","modifiedBy":"JKNABLE","dateModified":"2024-01-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F7A9C47-205B-25A2-E063-731AD00A2C59","beginDate":"2024-01-21","endDate":null,"createdBy":"JKNABLE","dateCreated":"2024-01-21","modifiedBy":"JKNABLE","dateModified":"2024-01-21","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2435022","version":"1","preferredName":"Disease, Disorder or Finding","preferredDefinition":"Specification of human conditions relevant to cancer. This includes observations, test results, history, and other concepts relevant to characterization of human cancer-related conditions. Non-neoplastic conditions of interest are also included.","longName":"C7057","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D9-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"14679064","version":"1","preferredName":"Metastasis Origin Anatomic Site","preferredDefinition":"The spread or migration of cancer cells from one part of the body (the organ in which it first appeared) to another. The secondary tumor contains cells that are like those in the original (primary) tumor._The place where something begins or comes from in either the sense of a physical location or a metaphysical source._Named locations of or within the body.","longName":"14679064v1.00","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Metastasis","conceptCode":"C19151","definition":"The spread or migration of cancer cells from one part of the body (the organ in which it first appeared) to another. The secondary tumor contains cells that are like those in the original (primary) tumor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Origin","conceptCode":"C42703","definition":"The place where something begins or comes from in either the sense of a physical location or a metaphysical source.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Anatomic Site","conceptCode":"C13717","definition":"Named locations of or within the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0F182743-3D14-6C5C-E063-731AD00AB59F","latestVersionIndicator":"Yes","beginDate":"2024-01-16","endDate":null,"createdBy":"JKNABLE","dateCreated":"2024-01-16","modifiedBy":"JKNABLE","dateModified":"2024-01-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"TCIA:TheCancerImagingArchive","workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"0F182743-3D15-6C5C-E063-731AD00AB59F","latestVersionIndicator":"Yes","beginDate":"2024-01-16","endDate":null,"createdBy":"JKNABLE","dateCreated":"2024-01-16","modifiedBy":"JKNABLE","dateModified":"2024-01-21","changeDescription":null,"administrativeNotes":"1/21/24 Added PV and alt VM for \"2 = Gastrointestinal cancers\"/C3052. jk;  1/16/24 Created for TCIA Pretreat-MetsToBrain-Masks variable. jk","unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"6305258","version":"1","longName":"TCIA (The Cancer Imaging Archive)","context":"CIP","ClassificationSchemeItems":[{"publicId":"14678977","version":"1","longName":"Pretreat-MetsToBrain-Masks","context":"CIP"}]}],"AlternateNames":[{"name":"Primary","type":"TCIA Alt Name","context":"CIP"}],"ReferenceDocuments":[{"name":"PQT","type":"Preferred Question Text","description":"Primary Metastasis Origin","url":null,"context":"CIP"}],"origin":"TCIA:TheCancerImagingArchive","workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"0F2A4AFF-A3EF-0B16-E063-731AD00AAD7E","latestVersionIndicator":"Yes","beginDate":"2024-01-17","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2024-01-17","modifiedBy":"JKNABLE","dateModified":"2024-01-21","changeDescription":null,"administrativeNotes":"1/17/24 Created for TCIA Pretreat-MetsToBrain-Masks variable. bf","unresolvedIssues":null,"deletedIndicator":"No"}}